
Narayana Hrudayalaya Q2 FY26 Results: 20.3% YoY Revenue Growth, 28.3% EBITDA Growth
Narayana Hrudayalaya Ltd, a leading healthcare service provider in India, announced its financial results for the second quarter (Q2 FY26) ended September 30, 2025. The company reported a consolidated operating revenue of INR 16,438 Mn, reflecting a YoY growth of 20.3% and EBITDA of INR 4,265 Mn, reflecting a YoY growth of 28.3%. The India revenue stood at INR 12,347 Mn and Cayman revenue was INR 4,316 Mn. The consolidated PAT stood at INR 2,583 Mn, reflecting a margin of 15.7%. The company has received a prestigious award for Clinical Governance from International Hospital Federation (IHF) and American college of Healthcare executives (ACHE) and expanded its quaternary care with Bone Marrow Transplant Services (BMT) in the quarter.
Key Highlights
- Consolidated operating revenue at INR 16,438 Mn with YoY growth of 20.3%
- EBITDA of INR 4,265 Mn with YoY growth of 28.3%
- India revenue at INR 12,347 Mn and Cayman revenue at INR 4,316 Mn
- Consolidated PAT at INR 2,583 Mn with YoY growth of 29.6%
- Received prestigious award for Clinical Governance and expanded quaternary care with Bone Marrow Transplant Services (BMT)